Leggett Thomas has filed 12 insider transactions across 1 company since May 2024.
Most recent transaction: a sale of 1274 shares of Stoke Therapeutics, Inc. ($STOK) on March 17, 2026.
Activity breakdown: 0 open-market purchases and 5 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 17, 2026 | Stoke Therapeutics, Inc. | $STOK | Leggett Thomas | Chief Financial Officer | S | Common Stock | 1274 | $32.74 | 13,476.0000 | 60,397,681 | 8.64% | 0.00% |
| March 17, 2026 | Stoke Therapeutics, Inc. | $STOK | Leggett Thomas | Chief Financial Officer | S | Common Stock | 922 | $33.38 | 12,554.0000 | 60,397,681 | 6.84% | 0.00% |
| March 18, 2026 | Stoke Therapeutics, Inc. | $STOK | Leggett Thomas | Chief Financial Officer | S | Common Stock | 172 | $31.79 | 10,209.0000 | 60,397,681 | 1.66% | 0.00% |
| March 18, 2026 | Stoke Therapeutics, Inc. | $STOK | Leggett Thomas | Chief Financial Officer | S | Common Stock | 2173 | $31.28 | 10,381.0000 | 60,397,681 | 17.31% | 0.00% |
| March 18, 2026 | Stoke Therapeutics, Inc. | $STOK | Leggett Thomas | Chief Financial Officer | S | Common Stock | 37 | $32.85 | 10,172.0000 | 60,397,681 | 0.36% | 0.00% |
| March 15, 2026 | Stoke Therapeutics, Inc. | $STOK | Leggett Thomas | Chief Financial Officer | M | Common Stock | 14750 | $0.00 | 14,750.0000 | 60,397,681 | 9999.99% | 0.02% |
| March 15, 2026 | Stoke Therapeutics, Inc. | $STOK | Leggett Thomas | Chief Financial Officer | M | Restricted Stock Units | 14750 | $0.00 | 44,250.0000 | 60,397,681 | 25.00% | 0.02% |
| Feb. 17, 2026 | Stoke Therapeutics, Inc. | $STOK | Leggett Thomas | Chief Financial Officer | A | Restricted Stock Units | 40000 | $0.00 | 40,000.0000 | 60,397,681 | 9999.99% | 0.07% |
| Feb. 17, 2026 | Stoke Therapeutics, Inc. | $STOK | Leggett Thomas | Chief Financial Officer | A | Employee Stock Option (Right to Buy) | 60000 | $0.00 | 60,000.0000 | 60,397,681 | 9999.99% | 0.10% |
| March 20, 2025 | Stoke Therapeutics, Inc. | $STOK | Leggett Thomas | Chief Financial Officer | A | Restricted Stock Units | 59000 | $0.00 | 59,000.0000 | 54,008,883 | 9999.99% | 0.11% |
| March 20, 2025 | Stoke Therapeutics, Inc. | $STOK | Leggett Thomas | Chief Financial Officer | A | Employee Stock Option (Right to Buy) | 89000 | $0.00 | 89,000.0000 | 54,008,883 | 9999.99% | 0.16% |
| May 15, 2024 | Stoke Therapeutics, Inc. | $STOK | Leggett Thomas | Chief Financial Officer | A | Stock Option (Right to Buy) | 396200 | $0.00 | 396,200.0000 | 43,994,862 | 9999.99% | 0.90% |